Novartis AG
Change company Symbol lookup
Select an option...
NVS Novartis AG
FRBA FIRST BANK (Hamilton)
UNM Unum Group
LLY Eli Lilly and Co
BDC Belden Inc
TTM Tata Motors Ltd
HOG Harley-Davidson Inc
SKY Skyline Champion Corp
MMM 3M Co
MPX Marine Products Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Based in Switzerland
Company profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$79.06
Day's Change
-1.90 (-2.34%)
Bid
--
Ask
--
B/A Size
--
Day's High
79.72
Day's Low
78.58
Volume
(Heavy Day)

Today's volume of 614,333 shares is on pace to be much greater than NVS's 10-day average volume of 1,640,966 shares.

614,333

SumRidge Partners, LLC Announces Selection as an Eligible Seller to the New York Fed's Secondary Market Corporate Credit Facility (SMCCF)

11:25 am ET September 15, 2020 (BusinessWire) Print

SumRidge Partners, LLC, (SumRidge) a top-ranked electronic fixed income market maker, was designated by the Federal Reserve Bank of New York as an Eligible Seller to support the Secondary Market Corporate Credit Facility (SMCCF).

As an Eligible Seller in the Fed's SMCCF program, SumRidge Partners was selected for their ability to play a role in the Fed's effort to support market liquidity and ensure the strength of fixed-income markets. Tom O'Brien, CEO and President states "We appreciate the New York Fed choosing us to be an eligible seller for the program and believe leveraging our dynamic trading platform will help support the SMCCF program."

About SumRidge Partners, LLC

SumRidge Partners LLC is a top ranked principal based fixed income market maker, specializing in high yield and investment grade corporate bonds, municipal bonds, institutional preferred securities and emerging market bonds. SumRidge Partners was formed in 2010 following the aftermath of the financial crisis and subsequent liquidity shortfall that occurred within fixed income trading; operating as a premier, electronic based fixed income market maker. SumRidge uses its own balance sheet to facilitate flow trading, ensuring instantaneous execution for our diverse client base. SumRidge currently ranks among the top liquidity providers on most major electronic bond exchanges, leveraging the firm's technological strengths and an experienced sales and trading team.

For more information about SumRidge, visit www.sumridge.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200915006018/en/

SOURCE: SumRidge Partners, LLC

For SumRidge Partners, LLC: 
Carol Barden
201.898.2543
carol.barden@sumridge.com
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.